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Invited Commentary
Protecting the bowel of premature infants
(First published online 18 May 2011)
Necrotising enterocolitis (NEC) is a serious acquired gastro-
intestinal disease of the newborn, affecting 0·5–5 in 1000 live
births(1), accounting for 2 % of neonatal intensive care unit
admissions(2) and with a mortality rate ranging from 10 to
30 %(1). Mortality is especially high in those neonates with
perforated bowel requiring surgery. The disease is found
particularly in premature infants and may be on the increase
as a result of the increased survival of pre-term infants
weighing , 1000 g. After birth, the intestine must adapt to a
supply of enteral nutrients that are very different in compo-
sition from the amniotic fluid swallowed in the womb; it
appears that the intestine of premature infants is frequently
unable to adapt as effectively as that of term newborns. A
cascade of events is initiated, which may ultimately result
in the loss of intestinal barrier function, gut necrosis and
gut perforation. Surgery is needed to remove gangrenous gut;
thus, even if infants survive, they may be left with inadequate
intestine to absorb the required nutrients and have a lifelong
dependency on parenteral nutrition. It is very difficult to get
premature infants to grow at rates equivalent to their growth
rate in utero. Neonatologists are thus faced with a dilemma
when feeding babies born prematurely – introduce enteral
feeds very slowly, and accept suboptimal growth and all its
consequences, or introduce enteral feeds more quickly in the
hope of getting increased growth – but expose infants to the
risk of NEC due to the lack of adaptation.
Although we understand some of the factors that may pre-
dispose to NEC, we are still far from a full understanding of
how feed intolerance can ultimately have such catastrophic
consequences, and therefore also of how to prevent the dis-
ease. The type of enteral feed given is important – breast
milk is known to protect from NEC compared with formula
feeds(3,4), and microbial colonisation/invasion also has an
important role. Although various pathogens have been
involved in NEC ‘outbreaks’, with Clostridium spp. and,
more recently, Enterobacter sakazakii among the suspects(5,6),
NEC is not simply an infectious disease of the gut.
NEC is a difficult disease to study clinically – the disease is
extremely heterogeneous, it is difficult to study very sick pre-
mature infants, and what one measures in blood samples etc.
may be the consequence of multisystem organ failure, rather
than directly relating to the pathogenesis of gut failure. In
order to understand more about the disease, Sangild et al.(7)
have developed an elegant model of NEC in pre-term piglets
which reproduces many of the features of the clinical disease,
including a marked protective effect of the colostrum. In this
issue of The British Journal of Nutrition, they provide some
very provocative data obtained using this model(8). Their start-
ing hypothesis was that intra-amniotic lipopolysaccharide
(LPS) administration would decrease sensitivity to NEC, with
the rationale that prenatal exposure of the fetus to LPS
would accelerate gut maturation and improve bacterial toler-
ance. Intra-amniotic LPS exposure (with postnatal formula
feeding) not only decreased the severity of NEC compared
with formula-fed piglets, so that it was intermediate between
that of formula-fed pigs and colostrum-fed pigs, but also
resulted in improved villus height, enzyme activities and intes-
tinal permeability compared with formula-fed piglets. These
observations lead to many more questions than answers,
and intra-amniotic LPS administration is obviously not viable
as a clinically useful tool to decrease NEC incidence. However,
a further exploration of the mechanisms involved here could
ultimately yield what is so badly needed in NEC, either a
way of preventing the disease or of treating it. The authors
hypothesise that intra-amniotic LPS induces a state of
immune tolerance via differential regulation of a number of
genes. However, another intriguing aspect of their data is
the increased villus height and the activity of digestive
enzymes in piglets that received intra-amniotic LPS. The intes-
tinal epithelium is usually an area of very rapid cell division
and migration, with cells constantly being shed from the villi
into the lumen and being replaced by new cells from the
crypts. Recently, a cryptal stem cell niche has been identified
that expresses lgr5, and it appears to be these cells that are
responsible for regeneration(9). Crucially, NEC is not only a
disease in which epithelia are damaged, but also a disease
in which epithelial regeneration is impaired, presumably
mediated via some effect at, or damage to, the lgr5 stem cell
population. This epithelial regeneration can also be impaired
by the activation of toll-like receptor 4 (TLR4), which is acti-
vated by LPS(10,11). Should not intra-amniotic administration
of LPS therefore cause TLR4 activation, impaired epithelial res-
titution and an increase in NEC severity, rather than the
decrease observed by Cilieborg et al.? There is much contra-
dictory data on TLR4 activation in the intestine, as highlighted
recently(10), but it is possible that pre-term activation of TLR4
may produce a state of tolerance, in which the subsequent
responsiveness to TLR4 activators is impaired. The relationship
between TLR4-responsive cells and lgr5-positive cells in the
intestine is not currently known, but an understanding of
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this axis may ultimately lead to the prevention and treatment
of NEC and could also be very useful for therapy of other
inflammatory bowel conditions.
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